Indrashis Podder
Overview
Explore the profile of Indrashis Podder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
927
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Podder I, Pesque D, Carron N, Gonzalez Torres P, Pujol R, Gimenez-Arnau A
Clin Transl Allergy
. 2025 Jan;
15(1):e70027.
PMID: 39809718
Background: Gut microbial involvement has been speculated in chronic spontaneous urticaria (CSU). The aim of the study was to compare the gut microbiome composition and diversity in CSU patients uncontrolled...
2.
Sarkar R, Dogra S, Vinay K, Sinha S, Narayan V, Kumaran M, et al.
Clin Cosmet Investig Dermatol
. 2024 Dec;
17:2875-2886.
PMID: 39717835
Background: Tacrolimus, a topical calcineurin inhibitor (TCI) with immunomodulatory effects, is considered a viable treatment option for vitiligo. A consensus building exercise was undertaken to determine the role and clinical...
3.
Podder I, Salman A, Asero R, Teresa Caballero M, Caffarelli C, De Las Vecillas L, et al.
Expert Rev Clin Immunol
. 2024 Nov;
20(12):1427-1435.
PMID: 39555837
Introduction: There is a significant prevalence of chronic spontaneous urticaria (CSU) in children across the globe. Some children with CSU do not achieve disease control with first-line antihistamine treatment and...
4.
Rothermel N, Vera Ayala C, Goncalo M, Fok J, Herzog L, Kocaturk E, et al.
Am J Clin Dermatol
. 2024 Nov;
26(1):61-75.
PMID: 39535577
Urticarial vasculitis (UV) is a rare and difficult-to-treat, small-vessel leukocytoclastic vasculitis presenting with recurrent long-lasting wheals. So far, no guidelines and treatment algorithms exist that could help clinicians with the...
5.
Poddar S, Chandra S, Podder I
Indian Dermatol Online J
. 2024 Jul;
15(4):685-686.
PMID: 39050061
No abstract available.
6.
Konstantinou G, Podder I
Cureus
. 2024 Jul;
16(5):e61453.
PMID: 38947573
Omalizumab, a humanized anti-IgE monoclonal antibody, is commonly employed in the treatment of antihistamine-refractory chronic spontaneous urticaria (CSU), where it significantly reduces free IgE levels, minimizing histamine release from basophils...
7.
Xiang Y, Fok J, Podder I, Yucel M, Ozkoca D, Thomsen S, et al.
Expert Opin Pharmacother
. 2024 Apr;
25(5):551-569.
PMID: 38654448
Introduction: Urticaria, a mast cell-mediated skin disease, manifests as acute or chronic, with the latter divided into spontaneous and inducible types and requires individualized management, including identifying triggers and comorbidities....
8.
Mondal H, Dhabal A, Mondal S, Podder I
Indian J Dermatol
. 2024 Apr;
69(1):106.
PMID: 38572049
Introduction: Urticaria is a common debilitating dermatological disorder impairing a patient's quality of life. Such patients are increasingly using socialmedia to manage their health and interact with peers, particularly during...
9.
Gimenez-Arnau A, Salman A, Podder I
Eur J Dermatol
. 2024 Apr;
34(1):3-12.
PMID: 38557452
Chronic spontaneous urticaria (CSU) is a relatively common dermatological disorder characterized by sudden and unpredictable onset of pruritic wheals and/or angioedema, for more than six weeks. It is a mast...
10.
Kapat A, Roy G, Bhattacharjee A, Mandal A, Bala A, Podder I
Indian J Dermatol
. 2023 Dec;
68(5):554-557.
PMID: 38099122
De Sanctis-Cacchione syndrome (DCS) formerly known as xerodermic idiocy is characterised by cutaneous photosensitivity, microcephaly, mental retardation, short stature, hypogonadism, spasticity, peripheral neuropathy and sensorineural deafness. Here in, we present...